Apollo Therapeutics
在场
高管
查看带有其 13 名主要高管的组织结构图
Apollo Therapeutics 搜索最多的简介
- Richard Mason, Chief Executive Officer and Director
- Jim Momtazee, Director
- Laura Furmanski, Director
创建提醒
跟踪 Apollo Therapeutics 的高管变动
生物技术
Apollo Therapeutics 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
- Metsera 刚刚宣布为 500 筹款数百万美元。 (公布2024十一月20号).
- TRexBio 刚刚宣布为 84 筹款数百万美元。 (公布2024十一月14号).
生物技术 行业的其他推荐联系人
消息
Apollo Therapeutics 的最新新闻稿
- Apollo Therapeutics Signs Exclusive Ex-China License From Sunshine Lake Pharma for Clinical-Stage FGF21 / GLP-1 Dual Receptor Agonist, a Therapeutic With Major Commercial Potential in Multiple Indications | Apollo Therapeutics
- Apollo Therapeutics and the University of Oxford enter into drug discovery and development collaboration | Apollo Therapeutics
- Apollo Therapeutics Announces Second Close Of Series C Financing Bringing Total Raised In Round To $260 Million » Apollo Therapeutics
- Apollo Therapeutics Closes $226.5 Million Series C Financing Led by Patient Square Capital » Apollo Therapeutics
- Apollo and ICR enter into collaboration for cancer drug development
- Apollo and ICR enter into collaboration for cancer drug development
- Avalo Therapeutics Transfers Anti-IL-18 Antibody, AVTX-007 (camoteskimab) to Apollo Therapeutics » Apollo Therapeutics
- Apollo Therapeutics and King’s College London enter into a strategic collaboration » Apollo Therapeutics
- Apollo Therapeutics Seeks to Build Drug War Chest With New Financing » Apollo Therapeutics
- Apollo Therapeutics Completes $145 Million Financing Led by Patient Square Capital to Expand and Advance Portfolio-Based Drug Development » Apollo Therapeutics
- View more press releases Close
通过电子邮件
